Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...

Finerenone use for 6 months was safe and associated with a significant 25% decrease in albuminuria for adults with type 1 diabetes and chronic kidney disease, according to data presented in the ...

The novel drug atacicept was associated with significant reductions in proteinuria vs. placebo with comparable safety and no ...

The rise in chronic kidney disease locally mirrors a global trend that experts say is caused by increasing occurrence of ...

Most people don't realise kidney disease starts silently. Mild swelling, fatigue, or changes in urine often appear long ...

Scarring is a key feature of chronic kidney disease. Now, University of Connecticut researchers report in Kidney ...

Kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI), represent a major global public health burden. These diseases cause ...

Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or ...

Dialysis may be preferred by some older people with kidney failure over conservative kidney management (a non-dialysis approach to kidney failure, focusing on managing kidney symptoms and prioritising ...

As part of the initial rollout, AQUAPASS will begin commercial deployment in selected medical centers across Israel, working closely with leading clinicians to collect clinical feedback and develop ...

In adults with stage IIIb–IV chronic kidney disease, the constipation drug lubiprostone did not reduce gut-derived uremic ...

With no new cases emerging in at least two weeks, officials say the lack of an "ongoing risk" justifies the lack of ...